Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase EARLY_PHASE1 × Pleural Effusion, Malignant × Sodium Chloride × Clear all

Phase

Phase EARLY_PHASE1 1 Phase 4 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Pleural Effusion, Malignant 1 Pancreatic Neoplasms 1 Neoplasms 1 Fatigue 1

Interventions

Sodium Chloride 1 Pleurodesis 1 Lidocaine 1 Chest Tubes 1 Anesthesia, Local 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05565014 2022-10-04

Safety and Efficacy Study of Virus Activated Killer Immune Cells (VAK) for Malignant Pleural and Peritoneal Effusion

Hubei Cancer Hospital

Phase EARLY_PHASE1 Unknown

Pleural Effusion, Malignant

Data powered by HemOnc (CC BY 4.0) Colophon ⚡